{"database": "lobbying", "table": "lobbying_activities", "rows": [[588693, "d4f87e7b-fb12-4de8-9909-8fac4f606b30", "Q1", "DALRYMPLE & ASSOCIATES, LLC", 5073, "EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)", 2008, "first_quarter", "MED", "Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.", null, 45000, null, 0, 0, "2008-04-14T13:47:10-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["588693"], "units": {}, "query_ms": 0.2958069962915033, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}